American Vietnamese Biotech Incorporation (HNX:AMV)

HNX:AMV Revenue

In the year 2025, American Vietnamese Biotech Incorporation had annual revenue of 154.07B VND, down -50.36%. American Vietnamese Biotech Incorporation had revenue of 39.52B in the quarter ending December 31, 2025, a decrease of -82.30%.

• Revenue: 154.07B
• Revenue Growth: -50.36%
• P/S Ratio: 1.53
• Revenue / Employee: 1.50B
• Employees: 103
• Market Cap: 235.99B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	154.07B	-156.29B	-50.36%
Dec 31, 2024	310.35B	113.78B	57.88%
Dec 31, 2023	196.57B	-85.25B	-30.25%
Dec 31, 2022	281.82B	57.98B	25.90%
Dec 31, 2021	223.84B	62.41B	38.66%